Literature DB >> 28230644

Expanding the Donor Pool Through Intensive Care to Facilitate Organ Donation: Results of a Spanish Multicenter Study.

Beatriz Domínguez-Gil1, Elisabeth Coll, José Elizalde, Jaime E Herrero, Teresa Pont, Brígida Quindós, Bella Marcelo, María A Bodí, Adolfo Martínez, Agustín Nebra, Francisco Guerrero, José M Manciño, Juan Galán, Miguel Lebrón, Eduardo Miñambres, Rafael Matesanz.   

Abstract

BACKGROUND: Intensive Care to facilitate Organ Donation (ICOD) may help to increase the donor pool. We describe the Spanish experience with ICOD.
METHODS: Achieving Comprehensive Coordination in Organ Donation (ACCORD)-Spain consisted of an audit of the donation pathway from patients who died as a result of a devastating brain injury (possible donors) in 68 hospitals during November 1, 2014, to April 30, 2015. We focused on possible donors whose families were interviewed to discuss organ donation once intensive care with a therapeutic purpose was deemed futile and brain death (BD) was a likely outcome.
RESULTS: Of the 1970 possible donors in ACCORD-Spain, in 257, the family was interviewed once the decision had been made not to intubate/ventilate (n = 105), with the patient under intubation/ventilation outside of the intensive care unit (n = 59), or with the patient intubated/ventilated within the intensive care unit (n = 93).Consent to ICOD was obtained in 174 cases. Consent was higher when the donor coordinator participated in the interview (odds ratio, 2.32; 95% confidence interval, 1.33-4.11; P = 0.003). One hundred thirty-one patients developed BD, of whom 117 transitioned to actual donation after BD. Of the 35 patients who did not develop BD, 2 transitioned to actual donation after circulatory death. Sixteen patients subject to ICOD were finally medically unsuitable organ donors.ICOD contributed to 24% of the 491 actual donors registered in ACCORD-Spain.
CONCLUSIONS: Despite the complexity of the interview, the majority of families consented to ICOD. Estimating the probability of BD and assessing medical suitability are additional challenges of the practice. ICOD represents a clear opportunity to increase the donor pool and ensures organ donation is posed at every end-of-life care pathway.

Entities:  

Mesh:

Year:  2017        PMID: 28230644     DOI: 10.1097/TP.0000000000001701

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Measures influencing post-mortem organ donation rates in Germany, the Netherlands, Spain and the UK : A systematic review.

Authors:  E Tackmann; S Dettmer
Journal:  Anaesthesist       Date:  2019-05-17       Impact factor: 1.041

Review 2.  A narrative review of family members' experience of organ donation request after brain death in the critical care setting.

Authors:  Nancy Kentish-Barnes; L A Siminoff; W Walker; M Urbanski; J Charpentier; M Thuong; A Sarti; S D Shemie; E Azoulay
Journal:  Intensive Care Med       Date:  2019-03-06       Impact factor: 17.440

Review 3.  Organ donation after circulatory death: current status and future potential.

Authors:  Martin Smith; B Dominguez-Gil; D M Greer; A R Manara; M J Souter
Journal:  Intensive Care Med       Date:  2019-02-06       Impact factor: 17.440

4.  Impact of Donation Physicians on Deceased Organ Donation: A Systematic Review.

Authors:  Janet E Squires; Laura D Aloisio; Wilmer John Santos; Danielle Cho-Young; Monica Taljaard; Nills Gritters; Sonny Dhanani; Gregory Knoll
Journal:  Can J Kidney Health Dis       Date:  2022-06-21

5.  Implementing of Active Brain-Dead Donor Identification Strategy in a Single Donor Center: One Year Experience.

Authors:  Akvilina Trilikauskienė; Irena Maraulaitė; Diana Damanskytė; Dovilė Lukminaitė; Neringa Balčiūnienė; Tomas Tamošuitis
Journal:  Medicina (Kaunas)       Date:  2020-07-22       Impact factor: 2.430

Review 6.  [Organ donation-Not only a responsibility of intensive care medicine].

Authors:  A Rand; T Koch; M Ragaller
Journal:  Anaesthesist       Date:  2021-12-06       Impact factor: 1.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.